News

The license grants Galenea the exclusive worldwide rights to develop, manufacture and commercialize the novel indole-based agonists, said Galenea. The licensed compounds have demonstrated potent 5-HT2C receptor agonist

When approved, the OraQuick hepatitis C virus (HCV) test is expected to be the first rapid HCV test approved by the FDA for use in the US. The

A total of 200 patients were enrolled in this 12-week, four-arm, parallel group Phase II clinical trial designed comparing 0.25mg, 0.5mg and 1mg once daily oral doses of

Mr Dodd was previously group finance director at Morse, a consulting, IT services and technology company. Before joining Morse in 2005, Mr Dodd held management positions at a

Hi-Tech’s dorzolamide ophthalmic solution is the generic for Merck’s Trusopt ophthalmic solution 2%, indicated for elevated intraocular pressure in patients with ocular hypertension or open-angel glaucoma. Hi-Tech said

Provectus is currently conducting Phase II clinical trials of its proprietary drugs PV-10 as a therapy for metastatic melanoma and PH-10 as a topical treatment for psoriasis and

In this position, Ms Perkins will continue to have responsibility for all of Infinity’s business functions, including corporate and product strategy, business development, finance, organizational development and human

The study is being conducted at clinical sites in the Netherlands and will enroll approximately 24 healthy subjects and six hepatitis C virus (HCV) infected patients. In this

New investor, HealthCare Ventures, led the round and Harold Werner, a partner with HealthCare Ventures, will join InfaCare’s board of directors. Additional funding came from new investor Longitude